Switch to:
Biomarin Pharmaceutical, Inc. (NAS:BMRN)
Additional Paid-In Capital
$2,059.1 Mil (As of Dec. 2013)

Biomarin Pharmaceutical, Inc.'s quarterly additional paid-in capital increased from Jun. 2013 ($1,864.0 Mil) to Sep. 2013 ($1,926.1 Mil) and increased from Sep. 2013 ($1,926.1 Mil) to Dec. 2013 ($2,059.1 Mil).

Biomarin Pharmaceutical, Inc.'s annual additional paid-in capital increased from Dec. 2011 ($1,197.1 Mil) to Dec. 2012 ($1,561.9 Mil) and increased from Dec. 2012 ($1,561.9 Mil) to Dec. 2013 ($2,059.1 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical, Inc. Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
AdditionalPaidInCapital 421.1485.6709.4794.9852.9900.01,090.21,197.11,561.92,059.1

Biomarin Pharmaceutical, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
AdditionalPaidInCapital 1,175.41,197.11,221.91,483.31,505.81,561.91,833.81,864.01,926.12,059.1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide